OrthoGrid Systems is launching the PhantomMSK Hip Preservation System, with applications for peri-acetabular osteotomy and treatment of femoral acetabular impingement.
Kuros Biosciences signed a private label agreement to supply bone graft material to SeaSpine, which will market the products as OsteoCurrent in the U.S. and select ex-U.S. markets.
SpinalCyte was issued a new patent in Canada, related to subjecting fibroblast cells to specific environments to differentiate into chondrocytes for use in joints and spinal discs.